Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism

S. M. Hutson, D. Berkich, P. Drown, Baiyang Xu, Michael Aschner, Kathryn F. LaNoue

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Because it is well known that excess branched-chain amino acids (BCAAs) have a profound influence on neurological function, studies were conducted to determine the impact of BCAAs on neuronal and astrocytic metabolism and on trafficking between neurons and astrocytes. The first step in the metabolism of BCAAs is transamination with α-ketoglutarate to form the branched-chain α-keto acids (BCKAs). The brain is unique in that it expresses two separate branched-chain aminotransferase (BCAT) isoenzymes. One is the common peripheral form [mitochondrial (BCATm)], and the other [cytosolic (BCATc)] is unique to cerebral tissue, placenta, and ovaries. Therefore, attempts were made to define the isoenzymes' spatial distribution and whether they might play separate metabolic roles. Studies were conducted on primary rat brain cell cultures enriched in either astroglia or neurons. The data show that over time BCATm becomes the predominant isoenzyme in astrocyte cultures and that BCATc is prominent in early neuronal cultures. The data also show that gabapentin, a structural analogue of leucine with anticonvulsant properties, is a competitive inhibitor of BCATc but that it does not inhibit BCATm. Metabolic studies indicated that BCAAs promote the efflux of glutamine from astrocytes and that gabapentin can replace leucine as an exchange substrate. Studying astrocyte-enriched cultures in the presence of [U14C]glutamate we found that BCKAs, but not BCAAs, stimulate glutamate transamination to α- ketoglutarate and thus irreversible decarboxylation of glutamate to pyruvate and lactate, thereby promoting glutamate oxidative breakdown. Oxidation of glutamate appeared to be largely dependent on the presence of an α-keto acid acceptor for transamination in astrocyte cultures and independent of astrocytic glutamate dehydrogenase activity. The data are discussed in terms of a putative BCAA/BCKA shuttle, where BCATs and BCAAs provide the amino group for glutamate synthesis from α-ketoglutarate via BCATm in astrocytes and thereby promote glutamine transfer to neurons, whereas BCATc reaminates the amino acids in neurons for another cycle.

Original languageEnglish (US)
Pages (from-to)863-874
Number of pages12
JournalJournal of Neurochemistry
Volume71
Issue number2
StatePublished - Aug 1998
Externally publishedYes

Fingerprint

Branched Chain Amino Acids
Metabolism
Astrocytes
Isoenzymes
Neurotransmitter Agents
Keto Acids
Glutamic Acid
Neurons
Glutamine
Leucine
Brain
Glutamate Dehydrogenase
Decarboxylation
branched-chain-amino-acid transaminase
gabapentin
Pyruvic Acid
Cell culture
Anticonvulsants
Placenta
Spatial distribution

Keywords

  • Astrocytes
  • Branched-chain amino acids
  • Gabapentin
  • Glutamate
  • Model

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Hutson, S. M., Berkich, D., Drown, P., Xu, B., Aschner, M., & LaNoue, K. F. (1998). Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. Journal of Neurochemistry, 71(2), 863-874.

Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. / Hutson, S. M.; Berkich, D.; Drown, P.; Xu, Baiyang; Aschner, Michael; LaNoue, Kathryn F.

In: Journal of Neurochemistry, Vol. 71, No. 2, 08.1998, p. 863-874.

Research output: Contribution to journalArticle

Hutson, SM, Berkich, D, Drown, P, Xu, B, Aschner, M & LaNoue, KF 1998, 'Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism', Journal of Neurochemistry, vol. 71, no. 2, pp. 863-874.
Hutson, S. M. ; Berkich, D. ; Drown, P. ; Xu, Baiyang ; Aschner, Michael ; LaNoue, Kathryn F. / Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism. In: Journal of Neurochemistry. 1998 ; Vol. 71, No. 2. pp. 863-874.
@article{b4cffa433867440a8017f66c78e4f41f,
title = "Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism",
abstract = "Because it is well known that excess branched-chain amino acids (BCAAs) have a profound influence on neurological function, studies were conducted to determine the impact of BCAAs on neuronal and astrocytic metabolism and on trafficking between neurons and astrocytes. The first step in the metabolism of BCAAs is transamination with α-ketoglutarate to form the branched-chain α-keto acids (BCKAs). The brain is unique in that it expresses two separate branched-chain aminotransferase (BCAT) isoenzymes. One is the common peripheral form [mitochondrial (BCATm)], and the other [cytosolic (BCATc)] is unique to cerebral tissue, placenta, and ovaries. Therefore, attempts were made to define the isoenzymes' spatial distribution and whether they might play separate metabolic roles. Studies were conducted on primary rat brain cell cultures enriched in either astroglia or neurons. The data show that over time BCATm becomes the predominant isoenzyme in astrocyte cultures and that BCATc is prominent in early neuronal cultures. The data also show that gabapentin, a structural analogue of leucine with anticonvulsant properties, is a competitive inhibitor of BCATc but that it does not inhibit BCATm. Metabolic studies indicated that BCAAs promote the efflux of glutamine from astrocytes and that gabapentin can replace leucine as an exchange substrate. Studying astrocyte-enriched cultures in the presence of [U14C]glutamate we found that BCKAs, but not BCAAs, stimulate glutamate transamination to α- ketoglutarate and thus irreversible decarboxylation of glutamate to pyruvate and lactate, thereby promoting glutamate oxidative breakdown. Oxidation of glutamate appeared to be largely dependent on the presence of an α-keto acid acceptor for transamination in astrocyte cultures and independent of astrocytic glutamate dehydrogenase activity. The data are discussed in terms of a putative BCAA/BCKA shuttle, where BCATs and BCAAs provide the amino group for glutamate synthesis from α-ketoglutarate via BCATm in astrocytes and thereby promote glutamine transfer to neurons, whereas BCATc reaminates the amino acids in neurons for another cycle.",
keywords = "Astrocytes, Branched-chain amino acids, Gabapentin, Glutamate, Model",
author = "Hutson, {S. M.} and D. Berkich and P. Drown and Baiyang Xu and Michael Aschner and LaNoue, {Kathryn F.}",
year = "1998",
month = "8",
language = "English (US)",
volume = "71",
pages = "863--874",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Role of branched-chain aminotransferase isoenzymes and gabapentin in neurotransmitter metabolism

AU - Hutson, S. M.

AU - Berkich, D.

AU - Drown, P.

AU - Xu, Baiyang

AU - Aschner, Michael

AU - LaNoue, Kathryn F.

PY - 1998/8

Y1 - 1998/8

N2 - Because it is well known that excess branched-chain amino acids (BCAAs) have a profound influence on neurological function, studies were conducted to determine the impact of BCAAs on neuronal and astrocytic metabolism and on trafficking between neurons and astrocytes. The first step in the metabolism of BCAAs is transamination with α-ketoglutarate to form the branched-chain α-keto acids (BCKAs). The brain is unique in that it expresses two separate branched-chain aminotransferase (BCAT) isoenzymes. One is the common peripheral form [mitochondrial (BCATm)], and the other [cytosolic (BCATc)] is unique to cerebral tissue, placenta, and ovaries. Therefore, attempts were made to define the isoenzymes' spatial distribution and whether they might play separate metabolic roles. Studies were conducted on primary rat brain cell cultures enriched in either astroglia or neurons. The data show that over time BCATm becomes the predominant isoenzyme in astrocyte cultures and that BCATc is prominent in early neuronal cultures. The data also show that gabapentin, a structural analogue of leucine with anticonvulsant properties, is a competitive inhibitor of BCATc but that it does not inhibit BCATm. Metabolic studies indicated that BCAAs promote the efflux of glutamine from astrocytes and that gabapentin can replace leucine as an exchange substrate. Studying astrocyte-enriched cultures in the presence of [U14C]glutamate we found that BCKAs, but not BCAAs, stimulate glutamate transamination to α- ketoglutarate and thus irreversible decarboxylation of glutamate to pyruvate and lactate, thereby promoting glutamate oxidative breakdown. Oxidation of glutamate appeared to be largely dependent on the presence of an α-keto acid acceptor for transamination in astrocyte cultures and independent of astrocytic glutamate dehydrogenase activity. The data are discussed in terms of a putative BCAA/BCKA shuttle, where BCATs and BCAAs provide the amino group for glutamate synthesis from α-ketoglutarate via BCATm in astrocytes and thereby promote glutamine transfer to neurons, whereas BCATc reaminates the amino acids in neurons for another cycle.

AB - Because it is well known that excess branched-chain amino acids (BCAAs) have a profound influence on neurological function, studies were conducted to determine the impact of BCAAs on neuronal and astrocytic metabolism and on trafficking between neurons and astrocytes. The first step in the metabolism of BCAAs is transamination with α-ketoglutarate to form the branched-chain α-keto acids (BCKAs). The brain is unique in that it expresses two separate branched-chain aminotransferase (BCAT) isoenzymes. One is the common peripheral form [mitochondrial (BCATm)], and the other [cytosolic (BCATc)] is unique to cerebral tissue, placenta, and ovaries. Therefore, attempts were made to define the isoenzymes' spatial distribution and whether they might play separate metabolic roles. Studies were conducted on primary rat brain cell cultures enriched in either astroglia or neurons. The data show that over time BCATm becomes the predominant isoenzyme in astrocyte cultures and that BCATc is prominent in early neuronal cultures. The data also show that gabapentin, a structural analogue of leucine with anticonvulsant properties, is a competitive inhibitor of BCATc but that it does not inhibit BCATm. Metabolic studies indicated that BCAAs promote the efflux of glutamine from astrocytes and that gabapentin can replace leucine as an exchange substrate. Studying astrocyte-enriched cultures in the presence of [U14C]glutamate we found that BCKAs, but not BCAAs, stimulate glutamate transamination to α- ketoglutarate and thus irreversible decarboxylation of glutamate to pyruvate and lactate, thereby promoting glutamate oxidative breakdown. Oxidation of glutamate appeared to be largely dependent on the presence of an α-keto acid acceptor for transamination in astrocyte cultures and independent of astrocytic glutamate dehydrogenase activity. The data are discussed in terms of a putative BCAA/BCKA shuttle, where BCATs and BCAAs provide the amino group for glutamate synthesis from α-ketoglutarate via BCATm in astrocytes and thereby promote glutamine transfer to neurons, whereas BCATc reaminates the amino acids in neurons for another cycle.

KW - Astrocytes

KW - Branched-chain amino acids

KW - Gabapentin

KW - Glutamate

KW - Model

UR - http://www.scopus.com/inward/record.url?scp=0031783654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031783654&partnerID=8YFLogxK

M3 - Article

C2 - 9681479

AN - SCOPUS:0031783654

VL - 71

SP - 863

EP - 874

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 2

ER -